Poll finds UK pharma's rep still high post-COVID

The UK pharma industry saw a spike in public trust and favourability amid the COVID-19 pandemic that, so far, shows little sign of wearing off, according to a new poll.

We want to get to know you better

Novartis ranked top for corporate reputation in dermatology

Novartis has been ranked the top pharma company in dermatology in a corporate reputation survey of skin condition patient groups.

Tracking studies: moving with the times

The benefits of Awareness, Trial, and Usage tracking can be enhanced if technology is introduced to bring responsiveness – and insights – in real time, as the business dictates.

US physicians favour biosimilars

As the US FDA moves towards issuing final guidelines on biosimilars, recent research with specialists in five main therapy areas suggests they are willing to embrace them if efficacy and safety